Salicylic Acid

Description

No description information is available for the specified drug.

Uses and Indications

This drug is indicated for the removal of common warts and plantar warts. Common warts are characterized by a rough, 'cauliflower-like' surface appearance, while plantar warts are specifically located on the bottom of the foot, presenting with tenderness and an interruption of the footprint pattern.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

The affected area should be washed thoroughly, and warts may be soaked in warm water for approximately 5 minutes to facilitate treatment. After soaking, the area must be dried completely.

Using the provided applicator, one drop of the medication should be carefully applied to each wart, ensuring that the wart is sufficiently covered. It is important to allow the application to dry completely before proceeding.

This procedure may be repeated once or twice daily as necessary, continuing until the wart is removed, for a maximum duration of 12 weeks.

Contraindications

Use of this product is contraindicated in the following situations:

Patients with diabetes or poor blood circulation should not use this product due to the increased risk of complications. Application is also contraindicated on genital warts, facial warts, or warts located on mucous membranes, as these areas may be sensitive and prone to adverse reactions. Additionally, the product should not be applied to moles, birthmarks, or warts with hair growth, as these conditions may alter the skin's response to treatment. Finally, use is contraindicated on irritated skin or any area that is infected or reddened, as this may exacerbate the condition and lead to further complications.

Warnings and Precautions

For external use only. This product is flammable; therefore, it must be kept away from fire or flame to prevent any risk of ignition.

The use of this product is contraindicated in individuals with diabetes or those who exhibit poor blood circulation. It should not be applied to genital warts, warts located on the face, or any mucous membranes. Additionally, it is not recommended for use on moles, birthmarks, or warts that have hair growing from them. Application on irritated skin or any area that is infected or reddened is also prohibited.

When utilizing this product, it is crucial to avoid contact with the eyes. In the event of accidental exposure, the eyes should be flushed with water for a minimum of 15 minutes. Users should also take care to avoid inhaling vapors during application. To ensure safety and efficacy, the bottle should be capped tightly after use and stored at room temperature, away from heat sources.

If discomfort persists after use, it is advised to discontinue use and consult a healthcare professional. This product should be kept out of reach of children. In the case of ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended.

Side Effects

Patients should be aware that this product is for external use only and is flammable; it should be kept away from fire or flame. The product should not be used by individuals who are diabetic or have poor blood circulation. Additionally, it is contraindicated for use on genital warts, warts on the face or mucous membranes, moles, birthmarks, or warts with hair growing from them. It should also not be applied to irritated skin or any area that is infected or reddened.

During the use of this product, if it comes into contact with the eyes, it is essential to flush the eyes with water for 15 minutes. Patients should avoid inhaling vapors and ensure that the bottle is capped tightly and stored at room temperature, away from heat.

Patients are advised to discontinue use and consult a doctor if discomfort persists. Furthermore, this product should be kept out of reach of children. In the event of accidental ingestion, medical help should be sought immediately, or contact a Poison Control Center.

Drug Interactions

There are currently no documented drug interactions associated with the use of this medication. Additionally, there is no information available regarding interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Salicylic Acid (wart remover liquid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients.

Due to the lack of data, it is advisable to closely monitor elderly patients for any potential adverse effects and to consider individual patient factors when determining the appropriateness of therapy.

Pregnancy

Pregnant patients should not use this medication if they have diabetes or poor blood circulation, as these conditions may pose additional risks during pregnancy. The use of this medication is contraindicated on genital warts, warts on the face or mucous membranes, moles, birthmarks, or warts with hair growing from them. Additionally, it should not be applied to irritated skin or any area that is infected or reddened. The potential effects on fetal outcomes have not been established, and caution is advised when considering treatment in pregnant patients. Healthcare professionals should weigh the benefits against the risks before prescribing this medication to women of childbearing potential.

Lactation

There is no specific information available regarding the use of this medication in nursing mothers or its effects during lactation. Healthcare professionals should consider the lack of data when advising lactating mothers about the use of this medication. It is recommended to monitor breastfed infants for any potential adverse effects if the medication is administered to a nursing mother.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the drug insert regarding dosage adjustments, special monitoring, or safety considerations. Therefore, healthcare professionals should exercise caution when prescribing this medication to individuals with reduced kidney function, as there is no available data to guide treatment decisions in this population. Regular monitoring of renal function may be prudent in these patients, although specific recommendations are not provided.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to this drug. Consequently, there are no dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the prescribing information.

Overdosage

In the event of an overdosage, immediate medical assistance is crucial. If the substance is ingested, healthcare professionals should advise patients or caregivers to seek medical help or contact a Poison Control Center without delay.

Prompt intervention is essential to mitigate potential adverse effects associated with overdosage. Symptoms may vary depending on the specific substance involved; therefore, a thorough assessment by a medical professional is recommended to determine the appropriate course of action.

Management procedures may include supportive care and symptomatic treatment, tailored to the individual patient's needs. Continuous monitoring and evaluation are advised to ensure patient safety and effective resolution of any complications arising from the overdosage.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the compound in these areas.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep this medication out of reach of children to prevent accidental ingestion. It is important to inform patients that if the medication is swallowed, they should seek medical help or contact a Poison Control Center immediately. This guidance is crucial to ensure the safety and well-being of patients and their families.

Storage and Handling

The product is supplied in a container that must be stored at a temperature range of 20°-25°C (68°-77°F). It is essential to close the container tightly after each use to prevent solidification. To maintain hygiene, the top of the bottle should be wiped clean following each application.

Care should be taken to avoid contact with surrounding skin during application. Additionally, the product should not come into contact with fabrics, floors, countertops, or other surfaces, as it may cause staining. It is also important to keep the product away from fire or flame. The product should be discarded when signs of the wart no longer appear.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Salicylic Acid, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)